Clobenzepam

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H18ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0O6W0NP518, chemically known as 10,11-dihydro-11-oxo-5h-dibenzo(b,e)(1,4)diazepine, 7-chloro-10-(2-(dimethylamino)ethyl)- but generally known as clobenzepam, which bears US NIH Compound Identifier 14396. European Medicines Agency schedules Clobenzepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06675MIG. The term CLOBENZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). CLOBENZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clobenzepam under HS 29339940 and SITC 51577. As of Q4 2014, CLOBENZEPAM remains the US FDA Preferred Term for this commodity. Clobenzepam bears US NLM identifiers UMLS ID C2699357 and NCI Concept Code C77434. SMILES: CLC1CC2[NH]C3C(C(=O)N(CCN(C)C)C2CC1)CCCC3.